What is the current Price Target for the Oncolytics Biotech Inc. stock?

The average Oncolytics Biotech Inc. target price is $3.74. This is 630.16% higher than the current stock price. The highest price target is 876.56%, the lowest is 485.94%. 4 Analysts have issued a price target Oncolytics Biotech Inc. 2026 .

How high will the Oncolytics Biotech Inc. stock rise?

No reliable answer can be given as to how high the Oncolytics Biotech Inc. stock will rise. The performance of stocks, including the Oncolytics Biotech Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Oncolytics Biotech Inc. stock today?

The performance of Oncolytics Biotech Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Oncolytics Biotech Inc. stock fall?

The decline in Oncolytics Biotech Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Oncolytics Biotech Inc. Forecast, price target & analysts

$0.49

3.67% today

Nasdaq, Apr 04, 07:42 pm CET

ISIN

CA6823108759

Symbol

ONCY

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Oncolytics Biotech Inc. Target price 2025 - Analyst rating & recommendation

Oncolytics Biotech Inc. Classifications & Recommendation:

Buy

100%

Oncolytics Biotech Inc. Price Target

Target Price	$3.74
Price	$0.51
Potential	630.16% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Oncolytics Biotech Inc. 2026 . The average Oncolytics Biotech Inc. target price is $3.74. This is 630.16% register free of charge higher than the current stock price. The highest price target is $5.00 876.56% register free of charge , the lowest is $3.00 485.94% register free of charge .
	A rating was issued by 4 analysts: 4 Analysts recommend Oncolytics Biotech Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Oncolytics Biotech Inc. stock has an average upside potential 2026 of 630.16% register free of charge . Most analysts recommend the Oncolytics Biotech Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.30	-0.29
	0.00%	3.33%
P/E		negative

3 Analysts have issued a Oncolytics Biotech Inc. forecast for earnings per share. The average Oncolytics Biotech Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.30	0.00%
2025	$-0.29 3.33% Unlock
2026	$-0.30 3.45% Unlock
2027	$-0.22 26.67% Unlock
2028	$0.20 190.91% Unlock
2029	$0.84 320.00% Unlock

Current	-1.69	51.01%
2025	-1.75 3.55% Unlock
2026	-1.69 3.43% Unlock
2027	-2.36 39.64% Unlock
2028	2.52 206.78% Unlock
2029	0.61 75.79% Unlock

Oncolytics Biotech Inc....

Current Oncolytics Biotech Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
H.C. WAINWRIGHT & CO., LLC	Locked ➜ Locked	Locked	Nov 12 2024
CANACCORD GENUITY	Locked ➜ Locked	Locked	Nov 11 2024
CANTOR FITZGERALD	Locked ➜ Locked	Locked	Nov 11 2024
RAYMOND JAMES LTD.	Locked ➜ Locked	Locked	Nov 11 2024
JONES TRADING	Locked ➜ Locked	Locked	Sep 18 2024

Analyst Rating	Date
Locked H.C. WAINWRIGHT & CO., LLC: Locked ➜ Locked	Nov 12 2024
Locked CANACCORD GENUITY: Locked ➜ Locked	Nov 11 2024
Locked CANTOR FITZGERALD: Locked ➜ Locked	Nov 11 2024
Locked RAYMOND JAMES LTD.: Locked ➜ Locked	Nov 11 2024
Locked JONES TRADING: Locked ➜ Locked	Sep 18 2024

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now